Before-the-Bell: Biocryst Shares Higher
634298
Shares of Biocryst Pharmaceuticals Inc. (BCRX.O) rose on Tuesday after the company received "orphan drug" status for an anti-cancer compound.
535175
BioSante releases more info on the pivotal studies for its lead drug.
741470
Shares of biotech company Biomira Inc. soared as it and a development partner, German drug maker Merck KGaA, reported Friday that the median survival in a study involving a lung cancer vaccine has yet to be reached after 23 months in a subset of patients.
328806
Shares of Protein Design Labs Inc (PDLI.O: Quote, Profile, Research) rose on Thursday after Swiss drugmaker Roche Holding AG (ROG.
613909
Shares of Biomira Inc. (BRA.TO: Quote, Profile, Research) surged 82 percent on Friday on promising test results for a new lung cancer vaccine developed by Germany&#39;s Merck (MRCG.
34170
LOS ANGELES (CBS.MW) -- Shares of Gilead Sciences climbed Thursday, touching a 52-week high at one point, after the biotechnology firm reported positive results from its recently approved HIV drug Truvada.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
688167
Shares in takeover target National Foods have pushed further ahead on the Australian Stock Exchange. Yesterday, they surged more than 5 per cent higher to $6.25, after Philippine food and drink giant San Miguel
149931
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in premarket trade Wednesday after the US Food and Drug Administration approved the companies&#39; multiple sclerosis drug Tysabri.
556197
Mining stocks led the FTSE higher on Thursday with Antofagasta, the copper producer focused on Chile, up 3.1 per cent to 476p on talk that a special dividend of up to 40 US cents a share could be paid when full-year results are announced on Tuesday.
644960
It began in July: Mylan Laboratories (nyse: MYL - news - people ) announced it would bid $4 billion in stock for King Pharmaceuticals (nyse: KG - news - people ). Investors were less than unanimously thrilled
567554
World&#39;s No.2 biotech company beats Wall Street consensus and raises its full-year profit forecast. NEW YORK  - Genentech Inc.
499386
Stocks rose sharply in early trading higher Thursday as investors gleaned positive consumer spending trends from retailers' June sales reports. A new bid for aluminum maker Alcan Inc. added to the market's upbeat mood.
768157
Biogen presents at the JPMorgan Healthcare Conference.
152243
Shares in BiogenIdec (BIIB:Nasdaq - news - research) and Elan (ELN:NYSE - news - research)rose early Monday after the companies released what they described as &quot;compelling&quot; phase III test results for their multiple sclerosis drug Antegren.
531085
Drug benefit manager Medco Health Solutions Inc.  on Wednesday reported a higher-than-expected quarterly profit on strong demand for mail-delivered generic medicines and raised its 2007 outlook, sending its shares to an all-time high.
412704
NEW YORK (CBS.MW) -- The Food and Drug Administration has approved Genzyme Corp. and Bioenvision Inc.&#39;s treatment for the most common type of childhood leukemia, sending shares of both companies higher Wednesday.